- Title
-
Novel cathepsin K inhibitors block osteoclasts in vitro and increase spinal bone density in zebrafish
- Authors
- Xue, S.T., Wang, Y.L., Han, X.W., Yi, H., Jiang, W., Si, S.Y., Guo, H.F., Li, Z.R.
- Source
- Full text @ RSC Adv.
Structures of Cat K inhibitors. |
Virtual screen found Cat K inhibitor 1x. (a) The 3D model of Cat K inhibitor 14 in docking position (PDB code 4dmy; the picture was prepared with Pymol) in the active site of Cat K and (b) comparison of the docking position of 1q (grey) with 14 (purple) and (c) structures, CDOCKER scores and Cat K IC50s of 14, 1q and 1x. |
Inactive compounds against Cat K. |
Molecular docking calculations of the binding mode of A22 with Cat K (PDB code: 4dmy). (a) and (b) The calculated interactions of A22 (grey) with amino acids (green) in the active pocket of Cat K. (c) Overlay of the crystal structures of Cat L (PDB code: 6ezp), Cat S (PDB code: 4bs5) and Cat B (PDB code: 6ay2) with Cat K. N161 (green) of Cat K located at a loop region where the conformations of the Cat L, S, B and K are different. Compared to the orientation of Y193 (purple) of Cat S, Y67 (green) of Cat K has much less clash with pyridine ring of A22. (d) Backbone carbonyl groups of N161 of Cat K, N286 (purple) of Cat S and D162 (yellow) of Cat L. |
(A) CTX-I detection of test compounds in the bone absorption process; (B) Effects on OC differentiation by test compounds in vitro. Three replicates were tested in each group. **Differences from the control group with probability p < 0.05. ***Differences from the control group with probability p < 0.001. The p value is calculated by Tukey–Kramer multiple comparisons test. The difference is considered statistically significant when probability p value is less than 0.05 and statistically highly significant when probability p value is less than 0.001. |
Binding curves of A20 and A22 dilutions. The affinities (KD) were calibrated with the steady state affinity 1 : 1 binding model using the evaluation software of Biacore 8K. |
Therapeutic effect of A22 in OP zebrafish. (A) Zebrafish spine fluorescence intensity data were collected within the white rectangle area. A22 was administered at a dose of 0.11 μM, 0.33 μM, 1.00 μM, and etidronate disodium (ED) was administered at a dose of 600 μM; (B) spine fluorescence intensity data were calculated based on values obtained from 30 fish each group. (C) A22 therapeutic effect on zebrafish OP. ***Differences from the model group with probability p < 0.001. The p value is calculated using Dunnett's T test and differences with probability p < 0.05 are considered statistically significant. PHENOTYPE:
|